. . . . . . . . . . . . . "p(SFAM:\"AKT Family\") -> p(RGD:Map2k1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "PI3-K activates Mapk3/Mapk1 in response to Ox-LDL through Akt. Pretreatment of VSMCs with wortmannin, a PI3-K inhibitor, significantly inhibited p42/44 MAPK activation. Transfection of cells with Akt-double negative plasmid significantly attenuated MEK1/2 phosphorylation." . . "Selventa" . . . . "2014-07-03T14:32:03.439+02:00"^^ . . .